GMRE - NYSE

Global Medical REIT Inc.

GMRE·NYSE

$35.74

-1.2%

Real EstateREIT - Healthcare Facilities

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$478.13M

EPS-0.9100

P/E Ratio-39.27

Earnings Date05/05/2026

1.24B

Assets

-1%

3Y-11.0%

5Y+13.0%

10Y+447.0%

712.40M

Total Liabilities

3Y-4.0%

5Y+11.0%

10Y+885.0%

530.07M

Total Equity

-5%

3Y-18.0%

5Y+16.0%

10Y+165.0%

Global Medical REIT Inc. Funding & Solvency Profile

GMRE · NYSE

Current Assets

Cash & Cash Equivalents9.08M

Net Receivables7.22M

Inventory0.00

Other Current Assets0.00

Total Current Assets16 M

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets150.48M

Long-Term Investments0.00

Other Non-Current Assets0.00

Total Non-Current Assets0

Total Assets

1.24B

Financial Health Analysis

Debt-to-Equity Ratio

1.34x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

16 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

1% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Global Medical REIT Inc. Balance Sheet

GMRE • NYSE

Global Medical REIT Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Aug 2014	Aug 2013	Aug 2012	Aug 2011
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	9.1M	6.8M	1.3M	4M	7.2M	5.5M	2.8M	3.6M	5.1M	19.7M	9.2M	163K	3.5K	12.3K	47.4K
Cash & Short-Term Investments	9.1M	6.8M	1.3M	4M	7.2M	5.5M	2.8M	3.6M	5.1M	19.7M	9.2M	163K	3.5K	12.3K	47.4K
Net Receivables	7.2M	7.7M	7M	8.2M	6.2M	25.8M	5M	11.6M	4.5M	212.4K	23.3K	2.8K	0.0	0.0	0.0
Accounts Receivables	0.0	7.4M	6.8M	8M	6.1M	25.8M	5M	2.9M	704K	212K	0.0	0.0	0.0	0.0	0.0
Other Receivables	0.0	270K	193K	200K	163K	0.0	0.0	0.0	0.0	0.0	23.3K	2.8K	0.0	0.0	0.0
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	37.7M	0.0	-468.2M	941.3K	11M	-278.1K	0.0	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	0.0	0.0	293K	183K	143K	0.0	0.0	19.3K	0.0	0.0	7.5K
Other Current Assets	0.0	2.8M	6.1M	18.3M	11.5M	10.8M	7.5M	3M	3.6M	0.0	901.9K	0.0	0.0	0.0	0.0
Total Current Assets	16.3M	17.3M	14.4M	30.5M	24.9M	42M	15.6M	9.7M	9.5M	22M	10.1M	197.2K	3.5K	12.3K	54.9K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	0.0	7.3M	11M	5M	3.8M	978.7M	3.1M	139K	426.3M	196.4M	55.1M	21.7M	0.0	0.0	0.0
Goodwill	5.9M	5.9M	5.9M	5.9M	5.9M	5.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	144.6M	54.1M	66M	91.3M	87.9M	52.3M	72.8M	36.3M	31.7M	7.1M	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	150.5M	60M	71.9M	97.2M	93.8M	58.2M	72.8M	36.3M	31.7M	7.1M	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	2.1M	0.0	0.0	0.0	0.0	2.2M	-636.1M	-471.8M	-227.3M	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	-2.2M	636.1M	471.8M	227.3M	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	0.0	1.2B	1.2B	1.3B	1.1B	22M	793.5M	590M	7.2M	1.8M	93.6K	309.5K	0.0	0.0	0.0
Total Non-Current Assets	150.5M	1.2B	1.3B	1.4B	1.2B	1.1B	869.3M	626.4M	465.1M	205.3M	55.2M	22M	0.0	0.0	0.0
Other Assets	1.1B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	1.2B	1.3B	1.3B	1.4B	1.3B	1.1B	884.9M	636.1M	474.6M	227.3M	65.3M	22.2M	3.5K	12.3K	54.9K
LIABILITIES
CURRENT LIABILITIES
Total Payables	0.0	33M	28.9M	29.6M	26M	7.3M	17.8M	11.7M	8.7M	4.8M	1.5M	213K	380.0	380.0	380.0
Accounts Payable	0.0	16.5M	12.8M	13.8M	10.3M	7.3M	5.1M	3.7M	2M	574K	683.9K	0.0	0.0	0.0	0.0
Other Payables	0.0	16.5M	16.1M	15.8M	15.7M	0.0	12.7M	8M	6.7M	4.2M	-683.9K	213K	380.0	380.0	380.0
Accrued Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	683.9K	176.2K	19K	7.5K	0.0
Short Term Debt	0.0	631.7M	585.3M	636.4M	514.6M	18.1M	347.5M	276.4M	0.0	27.7M	0.0	19.6M	0.0	0.0	0.0
Deferred Revenue	0.0	6.7M	5.1M	4.4M	0.0	0.0	0.0	0.0	0.0	3.2M	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	0.0	0.0	0.0	0.0	0.0	12.5M	0.0	-273.9M	-1M	-27.9M	38.9M	-19.6M	0.0	0.0	0.0
Total Current Liabilities	0.0	671.5M	619.3M	670.5M	540.6M	37.8M	365.3M	288M	173.6M	32.5M	1.5M	389.2K	19.4K	7.9K	380.0
NON-CURRENT LIABILITIES
Long Term Debt	0.0	14.4M	25.9M	57.7M	57.2M	586.6M	378.9M	315M	200.7M	66.1M	23.5M	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	424.6M	336.3M	212.8M	72.3M	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	3.2M	2M	1.3M	277.9K	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	0.0	7.3M	3.7M	5.5M	20M	15.8M	17.6M	5.2M	3.2M	-26.6M	847.2K	0.0	0.0	0.0	0.0
Total Non-Current Liabilities	0.0	29.1M	42.5M	73.7M	85.3M	605.3M	59.3M	48.3M	42M	39.8M	63.9M	19.6M	0.0	0.0	0.0
Capital Lease Obligations	0.0	7.5M	13M	10.5M	8.1M	3M	3.2M	2M	1.3M	277.9K	0.0	0.0	0.0	0.0	0.0
Total Liabilities	712.4M	700.6M	661.9M	744.2M	625.9M	643.1M	424.6M	336.3M	215.6M	72.3M	65.5M	20M	19.4K	7.9K	380.0
SHAREHOLDERS' EQUITY
Preferred Stock	124.1M	75M	75M	75M	75M	75M	75M	75M	75M	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	13K	67K	66K	66K	65K	49K	44K	26K	22K	17.6K	250.0	250.0	8K	5.5K	5.5K
Additional Paid-In Capital	0.0	734.2M	722.4M	722M	711.4M	504.8M	433.3M	243M	205.8M	172M	3M	3M	80K	49.5K	49.5K
Retained Earnings	-350M	-293.7M	-239M	-198.7M	-157M	-116.8M	-71.4M	-45M	-34.4M	-17M	-3.2M	-790.7K	-95.9K	-50.6K	-459.0
Accumulated Other Comprehensive Income/Loss	6.1M	18.6M	25.1M	34.7M	-6.6M	-18.2M	-6.7M	-3.7M	259M	155M	0.0	0.0	0.0	0.0	0.0
Other Total Stockholders' Equity	853.6M	0.0	0.0	0.0	0.0	-1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	509.8M	534.1M	583.6M	633M	622.8M	444.8M	430.3M	269.3M	246.3M	155M	-138.6K	2.2M	-15.9K	4.4K	54.5K
Total Equity	530.1M	555.9M	605.8M	649.1M	637.6M	457.8M	460.4M	299.8M	259M	200M	-138.6K	2.2M	-15.9K	4.4K	54.5K
Minority Interest	20.3M	21.8M	22.2M	16.1M	14.8M	13M	30.1M	30.5M	12.7M	45M	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	1.2B	1.3B	1.3B	1.4B	1.3B	1.1B	884.9M	636.1M	474.6M	227.3M	65.3M	22.2M	3.5K	12.3K	54.9K
Total Investments	0.0	2.1M	0.0	0.0	0.0	0.0	2.2M	-636.1M	-471.8M	-227.3M	0.0	0.0	0.0	0.0	0.0
Total Debt	0.0	653.6M	624.2M	704.7M	579.9M	607.6M	386.2M	315M	203.4M	66.5M	63.9M	19.6M	0.0	0.0	0.0
Net Debt	-9.1M	646.8M	622.9M	700.6M	572.6M	602.1M	383.4M	311.4M	198.3M	46.9M	54.8M	19.5M	-3.5K	-12.3K	-47.4K
Shares Outstanding	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149	2,675,149

SEC Filings

GMRE - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	March 03, 2026	March 02, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 02, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 26, 2026	January 23, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 04, 2025	December 03, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 18, 2025	November 13, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 13, 2025	November 13, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 05, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 04, 2025	November 04, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 08, 2025	October 08, 2025	2025	View Filing

Showing 1 to 10 of 269 filings

Related Guides

Blog Categories

Continue your GMRE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.